Front cover: Hypoglycemic activity of the Baker's yeast β‐glucan in obese/type 2 diabetic mice and the underlying mechanism
Mol. Nutr. Food Res. 2016, 60, 2678–2690.
DOI: 10.1002/mnfr.201600032
The yeast β‐glucan (BYGlc) orally given to diet‐induced obese/type 2 diabetic mice improves hepatic glucose‐lipid homeostasis. BYGlc decreases blood glucose through inhibiting intestine SGLT‐1 expression, and alters the gut microbiota by increasing Akkermansia population, which may be associated with reduced inflammation.
Source: Nahrung / Food - Category: Nutrition Authors: Yan Cao, Siwei Zou, Hui Xu, Mengxia Li, Zan Tong, Min Xu, Xiaojuan Xu Tags: Front Cover Source Type: research
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Men | Nutrition | Obesity